EAN News

EAN Treasurer, Jana Midelfart-Hoff reviews her "fantastic experience" in office over the last six months, representing the EAN and the Brain Health Mission on various levels

Welcome to the February 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2025.

For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis.

The EAN is delighted to announce the launch of the third cohort of our dedicated guideline education programme – CoCoCare (Cost-Conscious Healthcare) 2025.

The European Journal of Neurology and the European Academy of Neurology are launching a new benefit to reward our most productive reviewers from January 2024 onwards.

We are excited to introduce a new competition, Your EAN Congress Story, giving you the chance to win free registration for the EAN Congress 2025 in Helsinki, Finland on 21-24 June 2025!

A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe.

EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved!

Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!

The Lancet Neurology highlights the urgent need to prioritise brain health in a new editorial, citing the Brain Health Mission as an example of positive initiatives aiming to promote brain health.  

Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.

The EAN is proud to host the European Brain Health Summit 2025 on 19 March, from 09:00 to 12:00 CET, both onsite in Brussels, and streaming live via EAN.org

Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors.

Prof. Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology (starting July 2025) talks about her plans for the journal's future, as part of our series celebrating its 30th anniversary.